PluriSIn #1 (NSC 14613)SCD1 inhibitor CAS# 91396-88-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 91396-88-2 | SDF | Download SDF |
| PubChem ID | 225362 | Appearance | Powder |
| Formula | C12H11N3O | M.Wt | 213.24 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | NSC 14613 | ||
| Solubility | DMSO : ≥ 100 mg/mL (468.96 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | N'-phenylpyridine-4-carbohydrazide | ||
| SMILES | C1=CC=C(C=C1)NNC(=O)C2=CC=NC=C2 | ||
| Standard InChIKey | HUDWXDLBWRHCKO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C12H11N3O/c16-12(10-6-8-13-9-7-10)15-14-11-4-2-1-3-5-11/h1-9,14H,(H,15,16) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Stearoyl-CoA desaturase 1 (SCD1) inhibitor. Used to selectively eliminate undifferentiated human pluripotent stem cells (hPSCs) from culture; induces ER stress, attenuates protein synthesis and induces apoptosis in hPSCs. Prevents teratoma formation in immunocompromised mice. |
PluriSIn #1 (NSC 14613) Dilution Calculator
PluriSIn #1 (NSC 14613) Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.6896 mL | 23.4478 mL | 46.8955 mL | 93.791 mL | 117.2388 mL |
| 5 mM | 0.9379 mL | 4.6896 mL | 9.3791 mL | 18.7582 mL | 23.4478 mL |
| 10 mM | 0.469 mL | 2.3448 mL | 4.6896 mL | 9.3791 mL | 11.7239 mL |
| 50 mM | 0.0938 mL | 0.469 mL | 0.9379 mL | 1.8758 mL | 2.3448 mL |
| 100 mM | 0.0469 mL | 0.2345 mL | 0.469 mL | 0.9379 mL | 1.1724 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
NSC 14613 is a pluripotent cell-specific inhibitor (PluriSIn) that selectively eliminates human pluripotent stem cells (hPSCs) leaving a large array of progenitor and differentiated cells unaffected. Among 15 identified PluriSIns, NSC 14613 (also known as PluriSIn #1) is a derivative of N-acyl phenylhydrazine that shares a common structure moiety, phenylhydrazine (Ph-N[H,C]-NH) with 9 other PluriSIns. NSC 14613 is also an inhibitor of stearoyl-coA desaturase (SCD1) that inhibits the activity of SCD1 in hPSCs causing the imbalance between substrates and products and subsequently resulting in the accumulation of palmitate and stearate and the deprivation of oleate. Study results have suggested that NSC 14613 is able to induce ER stress, protein synthesis attenuation and apoptosis in hPSCs and can be used to prevent teratoma formation from tumorigenic undifferentiated cells.
Reference
Ben-David U, Gan QF, Golan-Lev T, Arora P, Yanuka O, Oren YS, Leikin-Frenkel A, Graf M, Garippa R, Boehringer M, Gromo G, Benvenisty N. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell. 2013 Feb 7;12(2):167-79
- Lu AA 47070
Catalog No.:BCC7977
CAS No.:913842-25-8
- CS 2100
Catalog No.:BCC6221
CAS No.:913827-99-3
- SC75741
Catalog No.:BCC5448
CAS No.:913822-46-5
- Ropinirole HCl
Catalog No.:BCC4939
CAS No.:91374-20-8
- 1''-Hydroxyerythrinin C
Catalog No.:BCN4066
CAS No.:913690-46-7
- Brexpiprazole
Catalog No.:BCC4118
CAS No.:913611-97-9
- AMG-458
Catalog No.:BCC3721
CAS No.:913376-83-7
- Almorexant hydrochloride
Catalog No.:BCC5123
CAS No.:913358-93-7
- LY 2087101
Catalog No.:BCC7869
CAS No.:913186-74-0
- ELN441958
Catalog No.:BCC6452
CAS No.:913064-47-8
- AT13387
Catalog No.:BCC2122
CAS No.:912999-49-6
- Sarafloxacin HCl
Catalog No.:BCC4713
CAS No.:91296-87-6
- 25-O-ethylcimigenol-3-O-beta-D-xylopyranoside
Catalog No.:BCN1309
CAS No.:914086-57-0
- 9-Nitrocamptothecin
Catalog No.:BCN8448
CAS No.:91421-42-0
- 9-Aminocamptothecin
Catalog No.:BCN2453
CAS No.:91421-43-1
- R788 disodium hexahydrate
Catalog No.:BCC5127
CAS No.:914295-16-2
- INCB024360 analogue
Catalog No.:BCC1647
CAS No.:914471-09-3
- Palomid 529
Catalog No.:BCC3905
CAS No.:914913-88-5
- BEZ235 (NVP-BEZ235)
Catalog No.:BCC3655
CAS No.:915019-65-7
- MDV3100 (Enzalutamide)
Catalog No.:BCC1268
CAS No.:915087-33-1
- 3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
Catalog No.:BCC8601
CAS No.:915095-94-2
- Bakkenolide IIIa
Catalog No.:BCN7352
CAS No.:915289-60-0
- Cot inhibitor-2
Catalog No.:BCC1497
CAS No.:915363-56-3
- Cot inhibitor-1
Catalog No.:BCC1496
CAS No.:915365-57-0
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen.[Pubmed:23318055]
Cell Stem Cell. 2013 Feb 7;12(2):167-79.
The use of human pluripotent stem cells (hPSCs) in cell therapy is hindered by the tumorigenic risk from residual undifferentiated cells. Here we performed a high-throughput screen of over 52,000 small molecules and identified 15 pluripotent cell-specific inhibitors (PluriSIns), nine of which share a common structural moiety. The PluriSIns selectively eliminated hPSCs while sparing a large array of progenitor and differentiated cells. Cellular and molecular analyses demonstrated that the most selective compound, PluriSIn #1, induces ER stress, protein synthesis attenuation, and apoptosis in hPSCs. Close examination identified this molecule as an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs. PluriSIn #1 was also cytotoxic to mouse blastocysts, indicating that the dependence on oleate is inherent to the pluripotent state. Finally, application of PluriSIn #1 prevented teratoma formation from tumorigenic undifferentiated cells. These findings should increase the safety of hPSC-based treatments.
